Boots To Divest OTC Business, Citing Market Consolidation
This article was originally published in The Tan Sheet
Executive Summary
Merger and acquisition activity in the OTC drug industry has prompted Boots the Chemists to put its healthcare unit up for saleYou may also be interested in...
Boots Healthcare International
Andrew Unitt is appointed Managing Director, effective Sept. 19. The exec has been Director of Finance since June 2002. Unitt joined Boots in 1995, working in various positions including Director of Finance for Do It All and Halfords. He replaces Paul Stoneham, who will "continue to assist Boots with the ongoing disposal process for BHI until then," the British company says. Boots announced plans to divest its OTC healthcare business earlier this year (1"The Tan Sheet" April 11, 2005, p. 13)...
Boots Healthcare International
Andrew Unitt is appointed Managing Director, effective Sept. 19. The exec has been Director of Finance since June 2002. Unitt joined Boots in 1995, working in various positions including Director of Finance for Do It All and Halfords. He replaces Paul Stoneham, who will "continue to assist Boots with the ongoing disposal process for BHI until then," the British company says. Boots announced plans to divest its OTC healthcare business earlier this year (1"The Tan Sheet" April 11, 2005, p. 13)...
Aleve Sales Still Hit By NSAID Publicity; Roche Integration On Track – Bayer
Sales of Aleve (naproxen sodium) continued to suffer during the second quarter due to NSAID class safety concerns, Bayer reported during an Aug. 10 earnings call from Leverkusen, Germany
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: